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Abstract Secretion to the periplasm of Escherichia coli enables 
production of many eukaryotic extracellular proteins in a soluble 
form. The complex disulphide bond arrangement of such proteins 
is probably a major factor in determining the low yield of 
correctly folded product observed in many cases. Here we show 
that co-expression of human protein disulphide isomerase 
increased the yield of a monoclonal antibody Fab' fragment in 
the periplasm of E. coil 
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I. Introduction 
Four components involved in disulphide bond formation in 
the periplasm of E. coli have been characterised: DsbA [1,2], 
DsbB [3,4], DsbC [5], and DsbD [6]. DsbA and DsbC act 
predominantly to oxidise proteins in vivo, although DsbC 
may have a greater ability to act as a disulphide isomerase 
than DsbA. DsbB is thought to re-oxidise molecules of DsbA 
that have become reduced during its function, whilst DsbD is 
thought to act as a reductase [6,7]. PDI is the best charac- 
terised protein of a growing family of related proteins in- 
volved in disulphide bond formation in the ER lumen of eu- 
karyotes that also includes ERp72 (CaBP2), CaBP1, and 
ERp61 [8-11]. PDI and DsbA are structurally related, both 
being members of the 'thioredoxin fold' family of proteins 
[12]. 
Various fragments of antibodies have been expressed in 
soluble and active form by secretion to the periplasm of E. 
coli. The effects on in vivo folding for such fragments of the 
co-expression of PDI, DsbA, and peptidyl-prolyl-cis trans- 
isomerase (PPIase) have been reported. No significant effects 
on antibody yield were observed [13]. PDI has however been 
shown to be associated with immunoglobulins in vivo, and 
involved in their folding in vitro [14,15]. Here we show that 
human PDI can have a significant effect on the yield of a Fab'  
fragment expressed in E. coli, in an assembled and soluble 
*Corresponding author. Fax: (44) (121) 414-6557. 
E-mail: p.a.lund@bham.ac.uk 
Abbreviations." Carb, carbenicillin; Cm, chloramphenicol; Fab', anti- 
body fragment with hinge containing the variable and first constant 
domains of both heavy and light chain; FCS, foetal calf serum (heat 
inactivated); IAA, 3-~-indole acrylic acid; IPTG, isopropyl [3-D- 
thiogalactopyranoside; PBS, phosphate buffered saline; PDI, protein 
disulphide isomerase; PPIase, peptidyl-prolyl-cis-trans-isomerase; 
TMB, 3,3',5,5'-tetramethylbenzidine; Tween-20, polyoxyethylenesor- 
bitan monolaurate. 
form, and that this enhancement may be substrate (Fab) spe- 
cific. 
2. Materials and Methods 
2.1. Reagents 
Carb, Cm, FCS, IAA, IPTG, TMB, Tween-20, and H202 were 
from Sigma and were of the highest purity available. Casein was 
from BDH. Bradford reagent was from Bio-rad. ELISA plates were 
96 well maxi-sorp Nunc plates. Dulbecco's modified Eagle medium 
(with sodium pyruvate, without L-glutamine) was from Gibco-BRL. 
The anti-human heavy chain antibody used in the assembly ELISA 
was a mouse monoclonal HP6045 purified from ATCC cell line ref. 
no. CRL 1757. This recognises the CH1 domain of all subclasses of 
human immunoglobulin. The anti human light chain conjugated to 
horseradish peroxidase used was GD12, purchased from The Binding 
Site, Birmingham, UK. The revealing antibody used in FACS analysis 
was a polyclonal phycoerythrin conjugated goat anti-human kappa 
from Southern Biotechnology Assoc. Inc., Birmingham, Alabama, 
USA. 
2.2. Bacterial strains, plasmids, and cell lines 
W3110, wild type E. coli, ATCC 27325; pDPH5, PDI expression 
plasmid, trp promoter, colE1 origin, Amp R, [16]; pCT54, Control 
plasmid for pDPH5, trp promoter, colE1 origin, Amp R, [17]; 
pAW6, A33~/1 Fab' expression plasmid, tac promoter, pACYC184 
origin, Cm rt, [18]; pMRR60, A33~4 Fab' expression plasmid, tac 
promoter, pACYC184 origin, Cm a, [18]; SW1222, Human colon can- 
cer cell line, with surface expressed A33 antibody antigen, [19]. 
2.3. E. coli growth conditions and periplasm extraction 
Luria-broth containing Cm at 50 ~tg-m1-1, Carb at 250 Ixg.m1-1 and 
IAA at various concentrations (0-80 pg.ml 1) shaken at 250 rpm, 
30°C was used throughout. 200 ml of L-broth in 2 litre baffled flasks 
were inoculated with cells concentrated by centrifugation to give an 
initial OD600=0.1. After growth to an OD600 of 0.5, a pre-induction 
sample quivalent to 1 ml at OD600=9 was taken before inducing Fab 
expression by addition of 1PTG to 0.2 mM. Samples were centrifuged 
for 10 min at 4500 rpm and cell pellets were stored on ice until 
resuspension in periplasmic extraction buffer (100 mM Tris-C1, 10 
mM EDTA pH 7.4) to a final volume of 300 ~tl. Cell suspensions 
were shaken overnight at 250 rpm, 30°C in 1.5 ml Eppendorf tubes 
and then centrifuged at 13,000 rpm in a microfuge. The supernatant 
was removed to a clean tube as the periplasmic fraction, and stored at 
-20°C until required. 
2.4. Analysis of Fab' concentration by assembly ELISA 
ELISA plates were coated overnight at 4°C with HP6045 at 2 
pg-ml 1 in PBS. After washing 4x with dH20, serial 1/2 dilutions 
of samples and standards were performed on the plate in 100 /.tl of 
sample/conjugate buffer (100 mM Tris-Cl pH 7, 100 mM NaC1, casein 
0.2% (w/v), Tween-20 0.0002% (v/v)), and the plate shaken at 250 
rpm, room temperature for 1 h. After washing 4× with dH20, 100 
pl of the revealing antibody GD12 was added, diluted 1/1000 in sam- 
ple/conjugate buffer and the plate shaken at 250 rpm, room tempera- 
ture for 1 h. After washing 4× with dH20, 100 ~tl of TMB substrate 
was added (0.1 M sodium acetate/citrate pH 6, 100 lag.m1-1 TMB, 
H202 0.01% (v/v)), and the A630 recorded using an automated plate 
reader. The concentration of Fab' in the periplasmic extracts were 
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calculated by comparison with purified Fab' standards of the appro- 
priate isotype. 
2.5. Culture of SW1222, and analysis of Fab' antigen binding by FACS 
analysis 
SW1222 was maintained by sub-culturing in Dulbecco's modified 
Eagle medium (with e-glutamine and 10% FCS added), at 37°C, 5% 
CO2. Adherent cells were removed from flasks by treatment with 
trypsin/EDTA (Gibco-BRL) for 5 min at 37°C, 5% CO2. Cells were 
washed twice, by centrifugation at 250xg, and re-suspension i  
equivalent culture volumes of medium. 100 lal of cell suspension con- 
taining 1 X 105 SW1222 cells was incubated at 4°C for 1 h with 100 ktl 
of 8 X concentrated/dialysed p riplasmic extract hat had been serially 
diluted in 'FACS buffer' (10% (w/v) BSA, 10% (w/v) FCS, 0.1% (w/v) 
sodium azide in PBS). The cells were washed with 'FACS buffer' 
before re-suspension i  200 I.tl 'FACS buffer' containing the phycoer- 
ythrin conjugated goat anti-human kappa revealing antibody at 1/ 
1000 dilution. After incubation at 4°C for 1 h, the cells were washed 
as described above, and resuspended in 200 ktl 'FACS buffer'. The 
fluorescent label bound to the cells was measured using a FACScan 
(Becton Dickinson). 
8 X concentrated/dialysed p riplasmic extract was prepared by ex- 
tracting 1 ml of 150 OD600.m1-1 bacterial cell pellet at 60 OD600.m1-1 
(2-fold concentrated) in periplasmic extraction buffer, as described 
above, dialysing overnight at 4°C in PBS using a 10 kDa molecular 
weight cut-off, then concentrating a further 4-fold using an Amicon 
ultra-filtration unit with a 5 kDa molecular weight cut-off membrane. 
The concentration of Fab' in these samples was determined by assem- 
bly ELISA. 
2.6. Protein concentration 
Periplasmic protein concentration was determined by the Bradford 
method, using BSA as a standard. 
3. Results 
3.1. Effect of the co-expression of  periplasmic human PDI on 
the yield of A3374 Fab' 
The PDI vector pDPH5 contains an OmpA-PDI  gene fu- 
sion under the control of the trp promoter. This results in the 
efficient expression of mature PDI to the periplasm of E. coli 
600 
500 
2g 
200 
lOO 
0 
0 5 10 15 20 25 
T ime post -Fab  induct ion  (hours )  
Fig. 1. Effect of PDI on the yield of A33y4 Fab. Closed squares (m) 
show the yield of A33T4 in periplasmic extracts prepared from a 
strain bearing the PDI expression plasmid pDPH5, whilst the open 
squares (ffl) show the yield from the control strain bearing pCT54 
both grown in the presence of 40 lag-m1-1 of IAA. Yields are 
ng-ml 1-OD6010, and the lines are the mean of three independent ex- 
periments. 
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Fig. 2. Effect of PDI on the yield of A3371 Fab. Filled symbols 
show the yield of A3371 in periplasmic extracts prepared from a 
strain bearing the PDI expression plasmid pDPH5 induced at 0, 20, 
40, and 80 gg.ml 1 IAA, whilst the open squares (E2) show the yield 
from the control strain bearing pCT54 grown in the presence of 80 
~g.m1-1 IAA. Yields are ng-ml-l.OD6010, and the lines are the mean 
of five independent experiments. 
when the cells are grown in the presence of the inducer IAA, 
as described previously [16]. This plasmid is compatible with 
those encoding the Fab's, enabling use of strains bearing both 
plasmids to investigate the effect of PDI on the folding of 
Fab's in the E. coli periplasm. 
Assembly ELISA was used as the method of assessing the 
concentration of Fab'  in periplasmic extracts. The antibody 
bound to the wells of the ELISA plate recognises only heavy 
chain, whilst the revealing antibody recognises only light 
chain. Therefore the absorbance measured gives an estimate 
of correctly folded and assembled Fab'.  
The effect of the co-expression of PDI on the yield of the 74 
humanised A33 Fab'  is shown in Fig. 1. When the expression 
of PDI was induced by including IAA at 40 pg.m1-1, the 
amount of A33 recovered was increased, to almost twice 
that seen in the control strain bearing pCT54 (plasmid lacking 
OmpA-PDI)  as its second plasmid. Inclusion of the PDI plas- 
mid under un-induced conditions (no IAA) gave an increase 
in the concentration of correctly assembled A33 Fab'  approxi- 
mately between the two curves shown in Fig. 1 (data not 
shown). We have shown previously that pDPH5 produces 
biologically active PDI under these conditions, although 
much less PDI than under inducing conditions [16]. Slowing 
of bacterial growth rate can increase the yield of proteins 
expressed in E. coli [20]. However, the increase in yield in 
the PDI expressing strain was not due to decreased growth 
rate, as indicated by culture density (data not shown). 
The yield of A33 and other Fab's in the periplasm increases 
to a peak a few hours after induction of Fab'  expression, and 
then rapidly decreases thereafter. This decrease probably due 
to the toxic effects of Fab'  expression as this period is also 
associated with decreased cell viability, and leakage of peri- 
plasmic proteins into fermentor growth media (N.W., unpub- 
lished data). 
3.2. Effect of the co-expression of periplasmic human PDI on 
the yield of A3371 Fab' 
The effect of PDI co-expression on the yield of soluble, 
assembled Fab'  was next evaluated for a different humanised 
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Fig. 3. Effect of PDI on the periplasmic extraction procedure. Col- 
umns 1 and 2 show the total protein concentration of periplasmic 
extracts made from strains bearing the A3374 Fab' plasmid 
pMRR60 and the PDI expression plasmid pDPH5, or the control 
plasmid pCT54, respectively. Both were grown in the presence of 40 
Ixg.m1-1 of IAA, and the results are the mean of three independent 
experiments. Cultures were harvested 2.5 h post-Fab induction. 
variant of A33 Fab', with a few amino acid substitutions in
the variable domains and with a Cal domain of 71 isotype. 
PDI expression was induced with 0, 20, 40, and 80 ~tg.ml 1 
IAA, but no increase in yield was observed, as shown in Fig. 
2. Indeed the peak yield of Fab' observed in the PDI co- 
expressing strain was lower than that for the strain carrying 
the control plasmid, although these differences were not sta- 
tistically significant. 
3.3. PDI dependent increase in A3374 Fab' is not an artifact 
of the periplasmic extraction procedure 
That the PDI dependent increase in Fab' yield was not due 
to differential leakiness, or more efficient periplasmic extrac- 
tion of strains expressing PDI, is shown in Fig. 3. If PD! 
expression affected the integrity of the cell or the extraction 
procedure, a corresponding increase in general periplasmic 
protein concentration after extraction would result. The total 
protein measured would not be biased directly by the presence 
of Fab' or PDI. Periplasmic extracts from cultures harvested 
2.5 h post-Fab' induction, that were grown identically to 
those in Fig. 1 and gave similar PDI dependent increases in 
Fab' yield were assayed for total protein concentration, using 
the Bradford method. There is no significant difference in 
total periplasmic protein concentration between the strain ex- 
pressing PDI to that without (compare columns 1 and 2, Fig. 
3), indicating that PDI alone does not increase the 'leakiness' 
of the W3110 E. coli strain. 
3.4. Correct folding and assembly ofA3374 Fab' as 
demonstrated by antigen binding 
Fab' concentration and assembly was determined by ELI- 
SA. In order to confirm that A3374 Fab' in periplasmic ex- 
tracts was functional and correctly folded as well as as- 
sembled, the binding of Fab' to cells bearing the 
uncharacterised A33 antigen was measured by FACS analysis. 
Bound Fab' was revealed with an anti-light chain antibody, in 
order that any weakly bound heavy chain was not measured 
--  heavy chains of some antibodies are known to have a weak 
antigen binding capacity (A.L., unpublished observation). Fig. 
4 shows that A3374 Fab' from strains both with and without 
PDI bind to the SW1222 cells. More total antigen binding 
capacity was detected from the strain co-expressing PDI, con- 
firming the result seen using assembly ELISA. No binding was 
observed by a periplasmic extract containing a control Fab' at 
similar concentrations. 
4.  D iscuss ion  
Previous studies howed that co-expression of PDI, DsbA 
or PPIase did not result in an increase in the yield of soluble, 
assembled IgA Fab in the E. coli periplasm. In contrast, we 
demonstrate here that in the case of a 74 humanised murine 
Fab', co-expression of PDI can increase the yield of Fab' 
produced in E. coli. The increase in yield shows some depen- 
dence on the concentration f PDI as higher levels of induc- 
tion of PDI, which are known to increase the levels of accu- 
mulated periplasmic PDI [16], result in greater yields of 
soluble assembled Fab'. 
The increase in A3374 Fab yield was shown not to be due 
to any PDI induced differences in periplasmic 'leakiness' or 
differential extraction of proteins. The Fab' in crude periplas- 
mic extracts was also shown to bind to antigen expressed on 
the surface of SW1222 cell line. This demonstrated that the 
Fab' measured in the assembly ELISA is correctly folded, 
since incorrect ertiary structure would disrupt the antigen 
binding pocket of the Fab'. Fab' in periplasmic extracts 
from the two strains (with/without PDI) has similar antigen 
binding affinity, as shown by the closely lying lines in Fig. 4. 
Western blots of reducing and non-reducing SDS-PAGE gels 
indicated that the heavy and light chains of assembled peri- 
plasmic A3374 Fab' were covalently associated (data not 
shown). 
In addition to increasing the specific yield of soluble 74 
Fab', PDI co-expression also increased the duration over 
which this higher specific yield is maintained. It is likely 
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Fig. 4. Binding of A33y4 Fab' in periplasmic extracts to SW1222 
colon cancer cells. 
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Fig. 5. Amino acid sequence and disulphide bonding patterns of the CH1 domains of A33y1 and A3374 Fabs. N.B. '*' denotes Cys residues 
forming intradomain disulphide bond, 'LC' denotes Cys forming disulphide bond to light chain, and 'Hinge' denotes free thiol in the hinge re- 
gion. Dissimilar amino acids are shown by a vertical dash. A3371 is encoded by pAW6 and is OmpA-vH2-CHI~/1 and OmpA-vL4-hu kappaC. 
A33"/4 is encoded by pMRR60 and is OmpA-vH1-CHI'~,4 and OmpA-vL2-hu kappaC. 
that the toxic effects of Fab' expression, which lead to de- 
creased cell viability after induction, are caused by incorrectly 
folded Fab'. Co-expression of PDI may reduce toxicity by 
reducing the proportion of incorrectly folded Fab'. This fea- 
ture could be particularly useful for production in fermentors, 
where it can be very difficult to judge accurately the optimal 
time to harvest he cells. 
Co-expression of PDI was found not to improve the yield 
of soluble assembled Fab' for the 71 humanised version of the 
same antibody. The two humanised variants have identical 
light chains, and although they differ by a few residues in 
their variable domains, none of these differences concerned 
cysteines or prolines, and most are conservative residue 
changes. It is likely that the differential effect of PDI co-ex- 
pression is mediated through effects on folding of the two 
different CH1 hinge regions. The amino acid sequences of 
these two regions are shown in Fig. 5. Although crystallo- 
graphic studies uggest 71 and 74 antibodies have intra-chain 
and inter-chain disulphide bonds in very similar conforma- 
tional locations, the position of the cysteines involved in the 
inter-chain bond in the primary sequence is very different. For 
the 71 variant, the two cysteines concerned in the intra-do- 
main disulphide would be translocated prior to those involved 
in the light-heavy and heavy-heavy interchain disulphides. For 
the ?4 variant, the cysteine involved in the light-heavy inter- 
chain disulphide would be translocated in advance of the cy- 
steines destined to form the intra-domain disulphide. Unlike 
the 71 variant herefore, the 74 variant has the opportunity to 
form an inappropriate intra-domain disulphide before trans- 
location of the second cysteine which should participate in 
formation of the appropriate intra-domain disulphide. A33 
74 Fab' heavy chain with this inappropriate disulphide may 
require the isomerase activity of PDI before progressing along 
its correct folding pathway. 
This interpretation is consistent with the observation that, 
in identical growth and induction conditions and using the 
identical expression vector and host strain, the yield of soluble 
assembled Fab' in the absence of co-expressed PDI is substan- 
tially greater for the 71 Fab' than for the 74 Fab' (data not 
shown). This interpretation is consistent also with the view 
that PDI only assists folding of proteins for which sponta- 
neous folding is restricted by some intrinsic structural feature 
conferred by the primary sequence. In the only previous re- 
port of similar studies [12] co-expression of human PDI did 
not give an increase in the yield of soluble assembled Fab'. It 
may be that this Fab', like the A3371 Fab', had no opportu- 
nity to form an inappropriate disulphide. Failure to achieve 
adequate xpression of PDI would be an alternative explana- 
tion, since our studies indicate high level PDI expression is 
required to give substantial yield improvement for A3374 
Fab'. The two plasmid system, used in our studies allowed 
the level and timing of PDI and Fab' expression to be con- 
trolled independently and PDI was accumulated to high level 
in the periplasm before induction of Fab' expression. PDI is 
very abundant in the ER lumen, so facilitation of Fab' folding 
may require high concentration of PDI in the periplasm be- 
fore translocation of the Fab' substrate. 
Acknowledgements: We thank Mukesh Sehdev for his helpful advice 
with shake flask culture and ELISAs, Andrew Chapman and Mari 
Spitali for help with antigen binding studies, and Dee Attwal for 
providing Fab' sequences. This work was funded by BBSRC and 
Celltech Ltd. 
References 
[1] Bardwell, J.C.A., McGovern, K. and Beckwith, J. (1991) Cell 67, 
581-589. 
[2] Kamitani, S., Akiyama, Y. and Ito, K. (1992) EMBO J. 11, 57- 
62. 
[3] Bardwell, J.C.A., Lee, J.O., Jander, G., Martin, N., Belin, D. and 
Beckwith, J. (1993) Proc. Natl. Acad. Sci. USA 90, 1038-1042. 
[4] Missiakas, D., Georgopoulos, C. and Raina, S. (1993) Proc. 
Natl. Acad. Sci. USA 90, 7084-7088. 
[5] Missiakas, D., Georgopoulos, C. and Raina, S. (1994) EMBO J. 
13, 2013-2020. 
[6] Missiakas, D., Schwager, F. and Raina, S. (1995) EMBO J. 14, 
3415-3424. 
[7] Bardwell, J.C.A. (1994) Mol. Microbiol. 14, 199-205. 
[8] Freedman, R.B. (1989) Cell 57, 1069 1072. 
[9] Mazzarella, R.A., Srinivasan, M., Haugejorden, S.M. and Green, 
M. (1990) J. Biol. Chem. 265, 1094-1101. 
[10] Fullekrug, J., Sonnichsen, B., Wunsch, U., Arseven, K., Nguyen 
Van, P., Soling, H.D. and Mieskes, G. (1994) J. Cell Sci. 107, 
2719 2727. 
[11] Srivastava, S.P., Fuchs, J.A. and Holtzman, J.L. (1993) Biochem. 
Biophys. Res. Commun. 193, 971-978. 
[12] Creighton, T.E. and Freedman, R.B. (1993) Curr. Biol. 3, 790 
793. 
[13] Knappik, A., Krebber, C. and Pluckthun, A. (1993) Bio/Technol- 
ogy 11, 77 83. 
[14] Roth, R.A. and Pierce, S.B. (1987) Biochemistry 26, 41794-182. 
[15] Lille, H., McLaughlin, S., Freedman, R. and Buchner, J. (1994) 
J. Biol. Chem. 269, 14290 14296. 
[16] Humphreys, D.P., Weir, N., Mountain, A. and Lund, P.A. 
(1995) in press. 
[17] Emtage, J.S., Angal, S., Doel, M.T., Harris, T.J.R., Jenkins, B., 
Lilley, G. and Lowe, T.J.R. (1983) Proc. Natl. Acad. Sci. USA 
80, 3671 3675. 
[18] Yarranton, G.T. and Mountain, A. (1992) in: Protein Engineer- 
ing -- a Practical Approach (Rees, A.R., Starnberg, M.J.E. and 
Wetzel, R. eds.) IRL Press, Oxford, pp. 303-326. 
[19] Leibovitz, A., Stinson, J.C., McCombs III, W.B., McCoy, C.E., 
Mazur, K.C. and Mabry, N.D. (1976) Cancer Res. 36, 4562 
4569. 
[20] Cabilly, S. (1989) Gene 85, 553 557. 
